Novavax awaits one more signature from the CDC before it can be used for public use.
“Today’s authorization offers adults in the United States who have not yet received a COVID-19 vaccine another option that meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization,” FDA Commissioner Robert Califf, MD, said in a statement.
Barely two-thirds of the nation is fully vaccinated against COVID-19, according to CDC estimates.
The two-dose adjuvanted series — which is an ingredient typical for vaccines intended to boost immune responses — has a 90.4 percent efficacy rate in adults.
Two days before the authorization, the federal government ordered 3.2 million doses of the vaccine in anticipation of the FDA giving the OK.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
